Ceniza, Bb Boy 1 -.
HRN: 25-92-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/22/2024
09/28/2024
IV
20mg
Q24h
Prematurity
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes